Project: Demography and Economics of Aging and Alzheimer’s Disease
7 Trends Reshaping the Health and Lifespans of America’s Rapidly Aging Population
Experts point to key dynamics challenging policymakers, health care planners, and families
Project: Demography and Economics of Aging and Alzheimer’s Disease
Experts point to key dynamics challenging policymakers, health care planners, and families
Project: Empowering Evidence-Driven Advocacy
Family Planning (FP) Budget Allocations Have Increased but Remain Small Share of Health Budget
Project: Empowering Evidence-Driven Advocacy
Katavi ina kiwango kikubwa ziaidi cha mimba za utotoni Tanzania.
Project: American Community Survey and Decennial Census Support Services
(2014) The U.S. population is undergoing significant racial/ethnic change, with rapidly growing Latino, Asian American, and multiracial populations.
Project: Empowering Evidence-Driven Advocacy
Karibu kila kijana wa kike aliyeolewa mmoja kati ya wane wenye umri kati ya miaka 15 hadi 19 wanatamani kutumia njia za uzazi wa mpango lakini kwa sasa hawatumii njia yoyote.
Project: Empowering Evidence-Driven Advocacy
The etonorgestrel (ENG)-releasing subdermal implant is a small plastic rod that is four centimeters in length and contains 68 milligrams of the progestin ENG. The implant is a long-acting reversible contraceptive method that is effective for three years. It must be inserted and removed by a trained provider and does not contain estrogen.
Project: Strengthening Evidence-Based Policy to Expand Access to Safe Abortion (SAFE ENGAGE)
Research has shown that in Côte d’Ivoire and around the world, abortion occurs among women of all ages and socioeconomic backgrounds, married or unmarried, and with or without children.
Project: Empowering Evidence-Driven Advocacy
The injectable contraceptive is a progestin-only dose of depot medroxyprogesterone acetate (DMPA), a progestin that mimics the natural progesterone hormone. Two DMPA formulas exist: One is administered into the muscle and one is administered into the tissue layer under the skin. The short-term reversible contraceptive method is effective for about three months. The injectable should be administered by a trained provider every three months to maintain protection from unintended pregnancies. The progestin-only injectable does not contain estrogen.